PUMA BIOTECHNOLOGY, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $121.2M | $213.3M | $69.2M |
| FY2025 | $86.0M | $216.3M | $29.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $121.2M | $213.3M | $69.2M |
| FY2025 | $86.0M | $216.3M | $29.6M |